Clinical Trials

Name of TrialDescription
​The Gilead – DIVERSITY Study​A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease.​ 
​Creatine Supplementation Study​​A study to evaluate dietary creatine supplementation for the reduction of mucosal inflammation through improved epithelial barrier function of active Ulcerative colitis.
​ADMIRE-CD II​A study to evaluate the safety and efficacy of Cx601, adult allogenic expanded adipose-derived stem cells, for the treatment of complex perianal fistula(s) in patients with Crohn’s disease.​

A study to evaluate the safety, tolerability and early proof of concept of TAK-018 for the prevention of postoperative Crohn’s disease recurrence.

Please contact Lucy Smigiel for more information:
Phone: 303-724-9143